About Duchesnay Pharmaceutical Group
Duchesnay Pharmaceutical Group is a Healthcare company based in Blainville (Canada) founded in 1970. It operates as an a multinational pharmaceutical company specializing in exporting innovative treatments worldwide. It operates on a B2B model. Its focus areas include Pharmaceuticals, Drug Manufacturing and International Exports. Its legal entity in India is Group Publishing India Llp (AAH-6698). Similar companies include Merck, Roivant Sciences, AbbVie, Gilead and Lilly and 5 more; 2 of its 10 listed similar companies have raised funding.
Company details
Duchesnay Pharmaceutical Group, established in 1970, excels in providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and international exports. A multinational pharmaceutical company specializing in exporting innovative treatments worldwide. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
- Headquarters Blainville, Canada
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website duchesnaypharmaceuticalgroup.com/en
- Legal Name Group Publishing India Llp
- Date of Incorporation 24 Oct, 2016
- Jurisdiction Bengaluru, Karnataka, India
Associated legal entities of Duchesnay Pharmaceutical Group
Duchesnay Pharmaceutical Group operates through Group Publishing India Llp (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Group Publishing India Llp CIN AAH-6698 | Active | 24 Oct 2016 | Bengaluru, Karnataka | – | – | 2 | View details |
Board of directors of Group Publishing India Llp (Duchesnay Pharmaceutical Group)
Group Publishing India Llp is the primary company behind Duchesnay Pharmaceutical Group. The board of Group Publishing India Llp currently have 2 directors; the longest-serving is Nischal Sukumaran, appointed in 2016. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Nischal Sukumaran DIN 07610573 | Designated Partner | 24 Oct 2016 | 9 yrs 11 mo | Group Publishing India Llp |
| Thomas Jay Schultz DIN 10730637 | Designated Partner | 03 Dec 2024 | 1 yr 10 mo | Group Publishing India Llp |
Similar companies to Duchesnay Pharmaceutical Group
Duchesnay Pharmaceutical Group has 10 listed similar companies in our database, 2 of them funded. They include Merck, Roivant Sciences, AbbVie, Gilead and Lilly, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| merck.com | 1891 | Kenilworth, United Kingdom | – | 781 | Pharmaceutical products are manufactured and marketed worldwide. | |
| roivant.com | 2014 | New York, United States | $1.3B | 662 | Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | |
| abbvie.com | 2012 | Chicago, United States | – | 8,667 | Biopharmaceutical research and drug development are conducted globally by AbbVie. | |
| gilead.com | 1987 | Foster, United States | – | 4,267 | Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | |
| lilly.com | 1876 | United States | – | 39,000 | Traditional pharmaceutical medicines are developed for multiple health fields. | |
| vrtx.com | 1989 | United States | – | 5,400 | Developer of drugs for the treatment of multiple disorders | |
| morphosys.com | 1992 | Planegg, Germany | – | 732 | Therapeutic antibodies for cancer and other diseases are developed. | |
| roche.com | 1896 | Basel, Switzerland | – | 2,382 | Pharmaceuticals and diagnostics kits are developed for various diseases. | |
| unither.com | 1998 | Silver Spring, United States | – | 1,168 | Treatments for chronic and life-threatening diseases are developed and commercialized. | |
| ascendispharma.com | 2007 | Hellerup, Denmark | $108.7M | 573 | Long-acting prodrug therapies are developed for endocrine and rare diseases. |
Detailed similar companies of Duchesnay Pharmaceutical Group
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Duchesnay Pharmaceutical Group
The website of Duchesnay Pharmaceutical Group (duchesnaypharmaceuticalgroup.com) receives about 1.5K visits a month.
- Monthly visits1.5K
▼ 2.7% vs previous month
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Duchesnay Pharmaceutical Group (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Duchesnay Pharmaceutical Group
Complete news archive for Duchesnay Pharmaceutical Group
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Duchesnay Pharmaceutical Group
Duchesnay Pharmaceutical Group was founded in 1970.
Duchesnay Pharmaceutical Group is headquartered in Blainville, Canada. It is registered at Blainville, Quebec, Canada.
Duchesnay Pharmaceutical Group, established in 1970, excels in providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and international exports. A multinational pharmaceutical company specializing in exporting innovative treatments worldwide. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
Duchesnay Pharmaceutical Group's top competitors include Merck, Roivant Sciences and AbbVie.
Duchesnay Pharmaceutical Group operates through Group Publishing India Llp.
The legal entities of Duchesnay Pharmaceutical Group currently have 2 directors, including Nischal Sukumaran, Thomas Jay Schultz.